Showing results (11-20 of 60) with videos related to
Sort By:
Pageof 6
Diabetes Research and Clinical Practice|March 10, 2022
The cardiovascular benefits of GLP1-RAs are related to their positive effect on glycemic control: A meta-regression analysisSamit Ghosal, Binayak SinhaDiabetes & Metabolic Syndrome|December 3, 2013
Pioglitazone--do we really need it to manage type 2 diabetes?Binayak Sinha, Samit GhosalJPMA. the Journal of the Pakistan Medical Association|February 1, 2017
Barriers and bridges to insulin therapy: bio psychosocial classificationSanjay Kalra, Samit GhosalFrontiers in Endocrinology|February 6, 2023
Finerenone in type 2 diabetes and renal outcomes: A random-effects model meta-analysisSamit Ghosal, Binayak SinhaDiabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 25, 2021
A Target HbA1c Between 7 and 7.7% Reduces Microvascular and Macrovascular Events in T2D Regardless of Duration of Diabetes: a Meta-Analysis of Randomized Controlled TrialsBinayak Sinha, Samit GhosalObesity (Silver Spring, Md.)|July 21, 2025
Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMABinayak Sinha, Samit GhosalDiabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 8, 2024
Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL StudyBinayak Sinha, Samit GhosalExpert Review of Clinical Pharmacology|April 24, 2020
Translating the statistical benefits of SGLT-2 inhibitors on cardio-renal outcomes into clinical practiceSamit Ghosal, Binayak SinhaFrontiers in Endocrinology|March 10, 2022
A Meta-Analysis of the Effect of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic Parameters in Patients With Polycystic Ovary SyndromeBinayak Sinha, Samit GhosalDiabetes & Metabolic Syndrome|March 23, 2013
Pioglitazone--do we really need it to manage type 2 diabetes?Binayak Sinha, Samit GhosalPageof 6